Patents by Inventor Michael Aarons

Michael Aarons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9540352
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: January 10, 2017
    Assignee: Pfizer Inc.
    Inventors: David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Michael Eric Green, Chakrapani Subramanyam
  • Patent number: 9527831
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson's disease.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: December 27, 2016
    Assignee: PFIZER INC.
    Inventors: Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green, Jaclyn Louise Henderson, Chewah Lee, Scot Richard Mente, Steven Victor O'Neil, Bruce Nelsen Rogers, Lei Zhang
  • Patent number: 9481129
    Abstract: A portable device for attaching a connector to an optical fiber, the optical fiber having an end, the device comprising means for receiving the optical fiber at the end of the optical fiber; and a connector station for autonomously attaching the connector to the optical fiber.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: November 1, 2016
    Assignees: COMMSCOPE CONNECTIVITY BELGIUM BVBA
    Inventors: Danny Willy August Verheyden, David Donald Erdman, Michael Gurreri, Randall Bobby Paul, Jan Watté, Robert Charles Flaig, Alan Edward Plotts, Michael Aaron Kadar-Kallen, Shelly Anne Buchter, Jan Vandenbroeck, Patrick Billet, Stefano Beri, André Johannes Maria Hilderink, Hernes Jacobs, Petrus Theodorus Rutgers, Petrus Theodorus Krechting, Martijn Johannes Wolbers, Walter Mattheus, Cristian-Radu Radulescu, Paul Vits, Karel Johannes Van Assenbergh, Pieter Cornelis Johan De Jager, Henk Jan Theodoor Van Der Pol
  • Publication number: 20160270876
    Abstract: Devices and methods for dispensing material from a dental handpiece. In one example, the method includes receiving an input that indicates that an amount of the material is to be dispensed from the container of the dental handpiece. The method also includes rotating an electric motor to rotate an imbalanced mass to vibrate a vibration transmission element that vibrates the material in the container. The method also includes dispensing the amount of the material from the container with a piston based on the input.
    Type: Application
    Filed: March 18, 2016
    Publication date: September 22, 2016
    Inventors: Michael Aaron Fisher, Robert Thomas St. Louis, Gopikrishnan Soundararajan, Matteo Riccardo Bosisio, Michael Carl Dunaway
  • Publication number: 20160270891
    Abstract: Vibration generator for generating mechanical vibrations for a dental handpiece, comprising a rotation driving means, a vibration generating element rotationally coupled to the rotation driving means and comprising an imbalanced vibrating portion and a vibrating element in mechanical communication with the vibration generating element, wherein the rotation of the vibration generating element causes the imbalanced vibrating portion to generate vibrations of the vibrating element and the vibrating element is configured to deliver the vibrations to an object.
    Type: Application
    Filed: March 20, 2015
    Publication date: September 22, 2016
    Inventor: Michael Aaron Fisher
  • Patent number: 9428523
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: August 30, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Patent number: 9417408
    Abstract: An interposer for optically coupling an optical device (OD) to a fiber, the OD mounted on a substrate, the interposer comprising: (a) a lens component comprising at least one lens for optically coupling with the OD the lens having a first optical axis, a first surface for mating with the substrate, and a second surface for mating with a third surface of a fiber component; (b) the fiber component comprising the third surface and a cavity for receiving at least one fiber and holding the fiber along a second optical axis, the first and second optical axes being perpendicular; and (c) wherein at least one of the lens component or the fiber component comprises a reflective surface for optically coupling the lens to a point along the second optical axis and adjacent the cavity.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: August 16, 2016
    Assignee: Tyco Electronics Corporation
    Inventor: Michael Aaron Kadar-Kallen
  • Patent number: 9403846
    Abstract: The present invention provides compounds of formula I, wherein the variables R1, R2, R5 and b are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: August 2, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Brian Thomas O'Neill, Christopher Ryan Butler, Erik Alphie LaChapelle
  • Publication number: 20160216454
    Abstract: A method for positioning an optical fiber having an end portion within an alignment groove of an alignment device includes orienting the optical fiber in the alignment groove of the alignment device; causing the optical fiber to elastically flex; using an interference point to assist in forming a curved profile of the flexed fiber, and using inherent elasticity of the flexed optical fiber to assist in retaining the end portion of the optical fiber in contact with the alignment groove. A connection system includes a connector, alignment device, and adapter, with an interference point on at least one of the connector, alignment device, or adapter.
    Type: Application
    Filed: September 24, 2014
    Publication date: July 28, 2016
    Inventors: Michael Aaron KADAR-KALLEN, Robert Charles FLAIG, Dwight A. BRETZ, Randall Bobby PAUL, Michael Lawerence GURRERI
  • Publication number: 20160177026
    Abstract: The present invention relates to absorbable block copolymers with improved characteristics including thermal stability, molecular weight consistency, inherent viscosity retention following melt extrusion, and fibers made from the polymers exhibit increased strength.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 23, 2016
    Applicant: Poly-Med, Inc.
    Inventors: Kenneth David Gray, JR., Michael Aaron Vaughn
  • Publication number: 20160178851
    Abstract: A fiber optic cable and connector assembly is disclosed. The assembly includes a cable optical fiber, a ferrule, a stub optical fiber having a first portion supported within the ferrule a second portion the projects rearwardly the ferrule and a signal modification structure optically coupled between the stub optical fiber and the cable optical fiber.
    Type: Application
    Filed: July 22, 2014
    Publication date: June 23, 2016
    Inventors: Yu LU, Michael Aaron KADAR-KALLEN
  • Publication number: 20160152637
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: February 9, 2016
    Publication date: June 2, 2016
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Publication number: 20160112409
    Abstract: Approaches for facilitating spatial and temporal verification of users and/or user devices are disclosed. In some implementations, a user device may be detected within a short wireless communication range. A wireless communication session with the user device may be initiated based on the detection. Information identifying a first integrity-based certificate may be received from the user device during the wireless communication session during a first time period. Information identifying a second integrity-based certificate associated with a second time period may be provided responsive to determining that the first integrity-based certificate is a valid integrity-based certificate associated with the first time period. The second integrity-based certificate may be configured to allow network access for the user device during the second time period.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 21, 2016
    Inventors: Michael Aaron LE, James YEAGER
  • Patent number: 9315520
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: April 19, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Patent number: 9300121
    Abstract: A magnetic wall cover system that includes an inner cover made at least partially of a ferrous material. The inner cover has an outer alignment surface. The magnetic wall cover system also has an outer cover that has an inner alignment surface. The outer cover is adapted to be removably mounted on the inner cover such that the inner alignment surface is in engaging relationship to the outer alignment surface when the outer cover is mounted over the inner cover. The magnetic wall cover system also includes at least one magnet disposed on the outer cover. The magnet is adapted to form a magnetic attraction between the magnet and the ferrous material of the inner cover.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: March 29, 2016
    Assignee: Belwith Products, LLC
    Inventors: Gary L. Myers, Michael Aaron Cohen, Alyssa M. Nelson
  • Patent number: 9260455
    Abstract: Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: February 16, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Jennifer Elizabeth Davoren
  • Publication number: 20160027313
    Abstract: According to an aspect, a method of performing environmentally-aware landing zone classification for an aircraft includes receiving environmental sensor data indicative of environmental conditions external to the aircraft. Image sensor data indicative of terrain representing a potential landing zone for the aircraft are received. An environmentally-aware landing zone classification system of the aircraft evaluates the environmental sensor data to classify the potential landing zone relative to a database of landing zone types as environmentally-aware classification data. Geometric features of the potential landing zone are identified in the image sensor data as image-based landing zone classification data. The potential landing zone is classified and identified based on a fusion of the environmentally-aware classification data and the image-based landing zone classification data.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 28, 2016
    Inventors: George Nicholas Loussides, Igor Cherepinsky, Michael Aaron Connor
  • Publication number: 20160016907
    Abstract: The present invention provides, in part, compounds of Formula I: N-oxides thereof, and pharmaceutically acceptable salts of the compounds or N-oxides; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds, N-oxides, or salts, and their uses for treating M1-mediated (or M1-associated) disorders including, e.g., Alzheimer's disease, schizophrenia (e.g., its cognitive and negative symptoms), pain, addiction, and a sleep disorder.
    Type: Application
    Filed: July 15, 2015
    Publication date: January 21, 2016
    Applicant: PFIZER INC.
    Inventors: MICHAEL AARON BRODNEY, JENNIFER ELIZABETH DAVOREN, MICHELLE RENEE GARNSEY, LEI ZHANG, STEVEN VICTOR O'NEIL
  • Publication number: 20160019735
    Abstract: An encrypted security system and associated methods for controlling physical access. The system includes a security server configured to receive a request for authentication from a mobile device, the request comprising information identifying the mobile device and a physical access control device. The security server forwards an encryption message comprising a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Application
    Filed: July 7, 2015
    Publication date: January 21, 2016
    Applicant: DELPHIAN SYSTEMS, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • Patent number: 9233981
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: February 2, 2014
    Date of Patent: January 12, 2016
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Brian Thomas O'Neill, Christopher Ryan Butler, Elizabeth Mary Beck